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Striatal binding of labeled glutamate to N-methyl-D-aspartate (NMDA) receptors, D,L-~-amino-3-hy- 
droxy-5-methyl-4-isoxazoleproprionic acid (AMPA) to quisqualate receptors and kainate to kainate 
receptors was examined in rats which had received unilateral decortications or unilateral striatal quinolinic 
acid lesions. One week after decortication, there were no significant changes in NMDA, quisqualate or 
kainate receptors in the striatum ipsilateral to the lesion, when compared to the striatum contralateral 
to the lesion. In contrast, binding to NMDA receptors was reduced by 92 %, to quisqualate receptors by 
80 % and to kainate receptors by 81% in striatum 3 months after quinolinic acid lesions. The reduction 
in NMDA receptor binding was significantly greater than the loss of quisqualate or kainate receptors. 
These results suggest that NMDA, quisqualate and kainate receptor recognition sites are located postsy- 
naptically in the striatum. These results also have implications for the quinolinic acid model of Hunt- 
ington's disease. 
Excitatory amino acids exert their actions through at least 3 distinct receptor types, 
named for N-methyl-D-aspartate (NMDA), quisqualate and kainate [14]. The major- 
ity of each of these receptor types appears to be located postsynaptically on dendrites 
or somata. Although somewhat controversial, it has been suggested that there are 
sub-populations of presynaptic NMDA [3, 5, 10], quisqualate [4] and kainate recep- 
tors [6]. The current study was undertaken to help clarify the synaptic localization 
of striatal NMDA, quisqualate and kainate receptors. 
Male Sprague-Dawley rats (20~230 g) were anesthetized and positioned in a 
Kopf stereotaxic frame. Unilateral striatal lesions were made with quinolinic acid at 
a dose of 60 nmol at uniform stereotaxic coordinates (i mm anterior to bregma, 2.5 
mm lateral to bregma and 5 mm deep from the cortical surface). Quinolinic acid was 
dissolved in 0.1 M phosphate buffer (pH 7.4) and injected in 0.5-1.0/A via a Hamil- 
ton syringe over a period of 8 min. After injection, the syringe was left in place for 
5 min prior to withdrawal. Animals with striatal lesions were allowed to survive for 
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3 months prior to sacrifice. For decortications, a dental drill was used to make a skull 
flap from about 3 mm posterior to 6 mm anterior to bregma, and 2 mm lateral to 
the mid-line to the lateral edge of the calvarium. After removal of  the skull flap, the 
underlying cortex was removed by aspiration and cortex lateral to the opening in the 
skull was undercut with a suture needle. One week after lesioning, the animals were 
sacrificed and the brains prepared for assay. 
Twenty/zm tissue sections were thaw-mounted on gelatin-coated slides. Sections 
received a 30 rain wash in ice-cold 50 mM Tris-acetate buffer (pH 7.20) to remove 
endogenous excitatory amino acids. For N M D A  receptor assays, tissue sections were 
incubated in 50 mM Tris-acetate buffer (pH 7.20) at 2'~C for 45 rain in the presence 
of 28 nM labeled L-glutamate. The incubation buffer contained 1 ItM quisqualate and 
I pM kainate to block binding to those receptor types. N M D A  (1 mM) was used 
to define non-specific binding. Quisqualate receptors were assayed by binding of 
AMPA in 50 mM Tris-HC1 buffer containing 2.5 mM calcium chloride and 100 mM 
potassium thiocyanate. Non-specific binding was determined in the presence of I mM 
unlabeled glutamate. Kainate receptors were labeled with [3H]kainic acid in 50 mM 
Tris-acetate buffer (pH 7.20). Non-specific binding was measured in the presence of 
I mM unlabeled glutamate. For all of  the assays, tissue sections were incubated for 
45 rain at 2"C. At the end of the incubation, sections received 3 quick rinses with 
ice-cold 50 mM Tris-acetate buffer followed by 2 quick rinses with cold 2.5 % gtutar- 
aldehyde in acetone. Sections were blown dry under a stream of  warm air. The total 
time from the end of the incubation until the slides were dried was 10 s. Dried sec- 
tions were placed in X-ray cassettes along with appropriate radioactive standards and 
were exposed to tritium-sensitive Hyperfilm (Amersham) for 2 3 weeks. The film was 
then developed, fixed and dried. Resultant autoradiograms were analyzed using an 
MCI D image processing system (Imaging Research, Inc., St. Catharine's, Ont., Can- 
ada). Serial sections from 3 decorticate and 3 striatal-lesioned rats were assayed and 
analyzed for NMDA,  quisqualate and kainate receptors. In both sets of  animals, 
binding in the striatum contralateral to the lesion served as the control [9]. In decorti- 
cate animals, dorsolateral portions of  the striatum were analyzed for receptor bind- 
ing. After quinolinate lesions, binding was measured in the central portions of the 
lesion and in corresponding areas of  the contralateral striatum. Binding ipsilateral 
to the lesion was compared with contralateral binding by paired t-test. 
Receptor binding was studied one week after decortication because studies of  high 
affinity glutamate uptake, a presynaptic marker,  show large decreases 1 2 weeks after 
decortication [9, 13]. Our use of the contralateral striatum as a control after decorti- 
cation may have resulted in a slight underestimation of any subsequent receptor 
changes, because there may be a small crossed corticostriatal projection. However, 
similar use of  the contralateral striatum as a control still results in a 40--55 % decrease 
in presynaptic glutamatergic markers ipsilateral to the lesion [9, 13]. 
Following unilateral decortication, there were no significant asymmetries in stria- 
tal binding to NMDA,  quisqualate or kainate receptors (Figs. 1 and 2). Although 
the binding of kainate was reduced to 83 +_ 3 % ipsilateral to the lesion, this did not 
reach statistical significance by paired t-test. 
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Fig. 1. Autoradiograms of binding to NMDA receptors (top), quisqualate receptors (center) and kainate 
receptors (bottom) in serial sections from rats with unilateral frontoparietal decortication (left) and unila- 
teral striatal quinolinate lesions (right). See text and Fig. 2. 
After striatal quinolinate lesions, N M D A  receptor binding was reduced by 92 %. 
Quisqualate and kainate receptors were reduced by 80 % and 81%, respectively. Ana- 
lysis of  variance indicated that the loss of  N M D A  receptors was significantly greater 
than the loss of  quisqualate or kainate receptors ( P <  0.05, ANOVA with N e w m a n -  
Keuls test). 
The results of  this study indicate that the majority of  striatal N M D A ,  quisqualate 
and kainate receptors are located postsynaptically. Based on excitatory amino acid 
release studies, it has been postulated that presynaptic N M D A  receptors exist in the 
olfactory tract [3], and hippocampus [5]. Furthermore, binding studies suggest the 
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Fig. 2. Histograms of binding to NMDA, quisqualate and kainate receptors in striatum of rats with unila- 
teral decortication (striped bars) and unilateral striatal quinolinate lesions (open bars). Percent control 
binding is expressed relative to binding in the striatum contralateral to the lesion. *P<0.05; **P<0.04; 
***P< 0.02; NS, not significant, 
The current study does not provide support for the notion that there are presynaptic 
NMDA receptors on the glutamatergic afferents to the striatum. 
Although a recent study has suggested that up to 30 % of striatal quisqualate recep- 
tors may be located presynaptically on corticostriatal afferent terminals [4], our re- 
sults are not consistent with this hypothesis. The reasons for this discrepancy are 
unclear and may reflect subtle damage to the striatum from decortication in the for- 
mer study, or differences in assay conditions. 
The issue of presynaptic kainate receptors has been controversial [6, 7] and previ- 
ous binding studies in the cerebellum have not provided support for this hypothesis 
[10]. However, two previous binding studies in homogenate preparations have 
demonstrated small reductions in striatal kainate receptor binding after unilateral 
decortication [2, 8]. In this study, we have observed a small (17 %) but consistent de- 
crease in kainate binding ipsilateral to the decortication, but this did not reach statis- 
tical significance by paired t-test. The failure to reach significance may have been 
influenced by the small contralateral corticostriatal projection which might cause a 
slight contralateral decrease in binding as well. Nevertheless, we cannot entirely rule 
out the possibility that there is a small population of presynaptic kainate receptors 
located on corticostriatal afl'erents. 
Recently, quinolinic acid lesions of the striatum have been proposed as a relatively 
accurate model for Huntington's disease [1, 11]. Because quinolinate acts at the 
NMDA receptor [12], it has been suggested that excitotoxicity at this receptor may 
play a role in the pathogenesis of Huntington's disease. Consistent with this hypothe- 
sis, we have recently reported a 93 % reduction in NMDA receptors in the putamen 
of Huntington's disease patients; the loss of NMDA receptors was significantly 
greater than that of quisqualate receptors [15]. The current demonstration of a 92 % 
reduction in NMDA receptors, together with the fact that this reduction is signifi- 
cantly greater than that of quisqualate receptors, provides further support for the 
quinolinate striatal lesion model of Huntington's disease. 
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